HONG KONG — Defects in fatty acid-binding proteins (FABPs) may help to explain the pathology in some cases of schizophrenia and autism spectrum disorders (ASDs), possibly leading to the development of tailor-made therapies for those mental disorders, Japanese neuroscientists reported.